J Refract Surg. 2020 May 1;36(5):300-307. doi: 10.3928/1081597X-20200407-02.
To report 1-year visual and refractive outcomes following PRESBYOND Laser Blended Vision using non-linear aspheric micro-monovision with the MEL 90 platform (Carl Zeiss Meditec GmbH).
Data were collected retrospectively for all patients who underwent treatment for simultaneous correction of refractive error and presbyopia from June 2015 to June 2018. Only those patients who completed at least 6 months of follow-up were included in the study.
A total of 101 patients with a mean age of 51.05 ± 5.15 years (range: 40 to 65 years), of whom 38 patients had myopic and 63 patients had hyperopic refractive error with or without astigmatism, were included in the study. Mean preoperative spherical equivalent was -3.36 ± 1.86 diopters (D) in the myopia group and +1.75 ± 0.99 D in the hyperopia group. At 1 year, the mean spherical equivalent refraction was +0.13 ± 0.32 D in the distance eye and -1.42 ± 0.33 D (range: -0.88 to -2.50 D) in the near eye in the myopia group and -0.13 ± 0.24 D in the distance eye and -1.28 ± 0.31 D (range: -0.63 to -2.00 D) in the near eye in the hyperopia group. Two eyes in the hyperopia group underwent early enhancement for the near eye at 3 months. Ninety-seven percent of the patients in the myopia group and 96% in the hyperopia group were satisfied with their distance vision. Near vision satisfaction score was 95% for the myopia group and 89% for the hyperopia group.
At 1 year, the aspheric micro-monovision protocol resulted in satisfactory and fairly stable visual outcomes in both myopic and hyperopic individuals. [J Refract Surg. 2020;36(5):300-307.].
报告使用 MEL 90 平台(卡尔蔡司医疗技术有限公司)的非线性非球面微单视法进行 PRESBYOND Laser Blended Vision 术后 1 年的视力和屈光结果。
回顾性收集 2015 年 6 月至 2018 年 6 月期间接受屈光性近视和老视同时矫正治疗的所有患者的数据。仅纳入完成至少 6 个月随访的患者。
共纳入 101 例患者,平均年龄 51.05 ± 5.15 岁(范围:40 至 65 岁),其中 38 例为近视,63 例为远视,伴或不伴散光。近视组术前等效球镜为-3.36 ± 1.86 屈光度(D),远视组为+1.75 ± 0.99 D。1 年后,近视组远眼平均等效球镜为+0.13 ± 0.32 D,近眼为-1.42 ± 0.33 D(范围:-0.88 至-2.50 D);远视组远眼平均等效球镜为-0.13 ± 0.24 D,近眼为-1.28 ± 0.31 D(范围:-0.63 至-2.00 D)。远视组中有 2 只眼在术后 3 个月行近眼早期增强。近视组 97%和远视组 96%的患者对远视力满意。近视组近视力满意度评分为 95%,远视组为 89%。
1 年后,非球面微单视方案为近视和远视患者提供了满意且相对稳定的视觉效果。[J Refract Surg. 2020;36(5):300-307.]。